TJO-002

N/A

Report date: 2022/11/16 12:20:06
NME

Base Information

Drug NameTJO-002
Drug Alias NameTJO-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid FP receptor agonists
TargetsProstanoid FP receptor
Therapy Area/IndicationsGlaucoma, Open-AngleOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesTaejoon Pharm. Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTaejoon Pharm. Co Ltd
Inactive CompaniesN/A
Active IndicationsGlaucoma, Open-AngleOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A